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The contribution of diabetes mellitus to lower extremity amputations in four public sector 
hospitals in Cape Town, for 2009 and 2010. 
2. INTRODUCTION
Problem statement 
Diabetes is the most common non-communicable disease worldwide and contributes to 
substantial morbidity and mortality. The prevalence of diabetes is increasing and reaching 
epidemic proportions, with the largest increase being seen in developing countries, including 
South Africa
1-3
. Among the many complications of diabetes, lower extremity amputations are
common, with a leg being lost to diabetes s mewhere in the world every thirty seconds
4
. The




Motivation for the study 
Studies done in South Africa have shown that the care of diabetes in the public sector is 
suboptimal
10,11
. A study in the private sector in South Africa showed that by ensuring optimal
care of diabetic patients, long term glycaemic control and a decrease in complications and 
hospital admissions can be achieved 
12
.
Lower extremity amputations can be the result of complications due to poor glycaemic 












contribution that diabetes makes to the performance of lower extremity amputations. This 
study will attempt to begin to fill in this gap in South African data and the results will be 




This may in turn give an indication on the level of care of diabetic patients in Cape Town. 
3. LITERATURE REVIEW
Diabetes mellitus is defined as a metabolic disorder of multiple aetiologies, characterised by
chronic hyperglycaemia and glucose intolerance, resulting from defects in insulin secretion,
insulin action or both
1,14
.
The classification of diabetes has been revised by the World Health Organisation (WHO) and 
is now based on aetiology in the following four groups
1,14
:
1. Type 1 diabetes: Previously known as insulin-dependent and juvenile-onset diabetes,
can occur at any age but usually affects children and young adults. It results from
destruction, most commonly autoimmune, of the pancreatic beta cells. There is a lack
of insulin which is required for survival.
2. Type 2 diabetes: Previously known as non insulin-dependent diabetes, it is the most
common type of diabetes, accounting for more than 90% of cases. It can occur at any












associated with obesity. It is characterised by insulin resistance and/or abnormal 
insulin secretion, either of which may predominate, but both of which are usually 
present. Being the most common type of diabetes, often with an insidious onset, it 
causes the greatest morbidity and mortality in diabetic patients.   
3. Gestational diabetes: It is glucose intolerance of varying degrees of severity, which
appears or is recognized for the first time in pregnancy. Strict control of the mother’s
blood glucose is important to avoid complication for both mother and fetus. Women
who have had gestational diabetes are at increased risk of developing type 2 diabetes 
in later life.
4. Other specific types of diabetes: These are less common and include genetic
disorders, infections and diseases of the exocrine pancreas, endocrinopathies or as a 
result of drugs. 
Burden of disease 
The number of people with diabetes is increasing dramatically worldwide, resulting in an
increased burden not only on individuals, but also on health care systems. Where it has been 
noted that there has been a decline in the morbidity and mortality for some of the non-
communicable diseases, this has not be seen for diabetes. Diabetes is now the most common
non-communicable chronic disease globally
1-3
.
The latest estimates show that in 2010, there are 285 million adults worldwide with diabetes, 
a prevalence of 6.4% of the world population. This is predicted to increase to 439 million 














The increase in the number of adults with diabetes globally will be seen mostly in developing 
countries, where it is reaching epidemic proportions. Between 2010 and 2030, the predicted 
increase in the number of adults with diabetes is 69% for developing countries compared to 
20% in developed countries
2,3,15-18
.
This increase in developing countries is thought to be due to the increasing urbanization of 
rural populations, with urban residence being shown to be associated with a two to five fold 
increased risk of developing diabetes
18
. The main reason is an increased rate of obesity, a
major risk factor for developing diabetes (type 2). This is due to the change from a relatively 
healthy traditional rural pattern, to the urban, westernised lifestyle of increased food quantity, 
decreased food quality, decreased exercise, increased smoking and increased alcohol 
availability. It is also predicted that 70% of Africans will live in urban areas in 2025
17-19
.
Diabetes in sub-Saharan Africa 
Both the WHO and the International Diabetes Federation (IDF), have highlighted that Africa
will contribute significantly to this increased burden of diabetes in developing countries. Few
epidemiological studies focusing on the burden of diabetes and other non-communicable
diseases have been done in sub-Saharan African countries, resulting in scarce data mainly
because of the difficulty in undertaking these studies
17-19
.
The prevalence of diabetes in Africa was previously thought to be very low, with studies in a 
number of countries including Ethiopia, Ghana, Lesotho, Uganda and Malawi between 1960 
and 1985 showing a prevalence of less than 1%. There were two exceptions at that time, 












few countries where ongoing studies have taken place, showing a six to ten fold increase in 
the prevalence of diabetes over a ten year period, from the 1990’s to 2000’s. The prevalence 
rates of diabetes in African countries now range between 1.5 and 3.5%
17-19
.
The IDF has estimated that in 2010, 12.1 million people will have diabetes in sub-Saharan 
Africa, which will increase to 23.9 million in 2030. This is a projected growth of 98%, well 




In addition to this increased burden of people with non-communicable diseases, sub-Saharan
Africa is weighed under by an increasing burden of communicable disease such as
HIV/AIDS, Tuberculosis and Malaria. It is estimated that in 2020, non-communicable
diseases will overtake communicable diseases as a major cause of mortality. It must also be




Diabetes in South Africa
Few studies have been done and there is poor data on the prevalence of diabetes in South
Africa. Current estimates are that there are over 2 million people in South Africa with 
diabetes, a prevalence rate of 3.4%. There is also variation in different communities in South
Africa with the prevalence of diabetes amongst adults in the Coloured group in Cape Town 
being as high as 10.8%
19,22
.
Like the rest of sub-Saharan Africa, the number of patients with diabetes is expected to 













diabetes affects older adults between 40 and 60 years. With improved healthcare, many HIV 
infected adults will live long enough to develop diseases like diabetes. Also, with South 
Africa currently rolling out anti-retroviral treatment, including protease inhibitors which are 
associated with an increased incidence of new onset diabetes, the number of diabetics can be 




Complications of diabetes 
Diabetes is associated with acute and chronic complications, both of which contribute 
substantially to morbidity and mortality in diabetics. The main acute complications are 
diabetic ketoacidosis (DKA), hyperosmolar non-ketotic acidosis (HONK) and 
hypoglycaemia
14
. Being acute events, these conditions cause significant mortality, with 
mortality rates for sub-Saharan Africa of 10-30% for DKA and 41% for HONK being 
reported
19
. Hypoglycaemia is most often the result of the incorrect usage of glucose lowering 
diabetic medication, especially insulin. These conditions also contribute significantly to 




The chronic hyperglycaemia seen in diabetics leads to chronic complications, resulting in 
morbidity as well as mortality. This hyperglycaemia causes both microvascular and 
macrovascular complications. The microvascular complications are neuropathy, nephropathy 
and retinopathy. The macrovascular complications are cardiovascular disease, peripheral 
vascular disease and cerebrovascular disease
4,14
. Many diseases like Tuberculosis are also 
















The mortality rate for diabetes in sub-Saharan Africa increased from 2.2 to 2.5% in 2000, is 





Lower extremity amputations 
One of the most significant complications of diabetes is a lower extremity amputation. 
Studies have shown that up to 90% of lower extremity amputations done worldwide are 
associated with diabetes and up to 70% of patients undergoing a lower extremity amputation 
die within five years of the operation
6
. 
There is a wide range in the percentage of lower extremity amputations due to diabetes. 
Studies in Finland have shown that less than half of the amputations are due to diabetes, the 
USA that half are due to diabetes, and Germany that two thirds are due to diabetes
23,24
. There 
is a lack of information for Africa, with an unpublished study from South Africa in 1999 









 Long duration of diabetes 




 Peripheral neuropathy 













 Limb deformity 
 Infection 
 Trauma 
 Foot ulcer 
 Previous amputation 
 
Foot ulceration is one of the most important risk factors for a lower extremity amputation. 
The lifetime risk of a diabetic patient developing an ulcer is 25%, and up to 85% of lower 
extremity amputations are preceded by an ulcer
4-6
. In developed countries ulcers are usually 
due to peripheral vascular disease. In developing countries ulcers are usually due to 





What is of major concern is that the majority of the above risk factors are preventable, with 
simple clinical examinations, patient education and regular follow up. Unfortunately this is 




Cape Town healthcare services 
Cape Town is situated in the Western Cape province of South Africa. It has a heterogeneous 
population of about 3.5 million people, consisting of about 53.9% Coloured, 26.7% Black, 




Like the rest of South Africa, healthcare is split between the public and private sectors. It is 
estimated that 4.2 million of the 5.2 million people in the Western Cape, or 80%, are 
dependent on the public healthcare sector
28













secondary and tertiary levels of care. Diabetes and other chronic diseases are mostly cared for 
at the primary care level and cases are referred to the secondary and tertiary levels of care as 
necessary (for an amputation, the treatment of DKA, etc). Unfortunately the level of care of 
diabetes at this primary care is often suboptimal with inadequate screening to prevent 
complications due to diabetes, which results in the need for further treatment at the higher 




4. STUDY AIM AND OBJECTIVES 
 
The aim of this study is to describe the contribution of diabetes mellitus to lower extremity 
amputations in four public sector hospitals in Cape Town.  
 
The objectives of this study are: 
1. To determine the demographic characteristics of patients who underwent lower 
extremity amputations at public sector hospitals in Cape Town in 2009 and 2010  
2. To determine the proportion of these amputations due to diabetes 
3. To determine the cause/contributing factors for these amputations 
4. To determine associated co-morbid diseases 

















5. STUDY METHODS 
 
Study design 
The study is a record review of lower extremity amputation cases performed in four Cape 




Data will be obtained from four public sector hospitals performing lower extremity 
amputations in the western portion of the Cape Town Metropole, including Groote Schuur 
Hospital, a tertiary level hospital, and its associated secondary level hospitals, New Somerset, 
Victoria and GF Jooste Hospitals. Data is not available from private sector hospitals in the 




All patients seen at the four hospitals who had a lower extremity amputation as identified in 
the theatre register for 2009 and 2010 will be identified. From these theatre records, the 
patients’ folders will be accessed from the record departments. 
 
Inclusion and exclusion criteria 
All patients identified as having undergone a lower extremity amputation in the above 
mentioned hospitals in 2009 and 2010, with available records, will be enrolled in the study. 
Patients whose records are not available will not be included in the study, and this missing 













Definition of lower extremity amputations 
The definition of a lower extremity amputation (LEA) is the surgical removal of part of the 
lower limb by transection of the leg, foot or digit, and necessarily includes the removal of 
bone
8
. All cases including the terms: above knee amputation, through knee amputation, 
below knee amputation, supra-malleolar amputation, forefoot amputation and toectomy will 
therefore be included as lower extremity amputations in this study. 
 
Sample size 
The study sample will include all patients having undergone a lower extremity amputation in 
the above mentioned hospitals in 2009 and 2010, whose records are available. This number is 
estimated to be 1000 and will give more than 90% statistical power to estimate the true 
proportion of lower extremity amputations due to diabetes. 
 
Test Ho: p = 0.6000, where p is the proportion in the population 
Assumptions: Alpha = 0.0500 (two-sided) 
Expected proportion of diabetic patients = 60% 
True proportion = 65% 
Sample size n = 1000 
Estimated power = 90.4% 
 
Data collection 
The following information will be extracted from the patients’ folders using a standard 
questionnaire (Part D: Appendix 1): 
 













 Diabetic history 
 Co-morbid disease 
 Risk factors/cause 
 Amputation history 
 
Data analysis 
Data will be captured in Excel. Percentages for categorical data will be calculated. Measures 
of association between categorical variables will include Chi
2 
test and prevalence ratios with 
95% confidence interval. Assistance with data analysis will be sought from the University of 
Cape Town, School of Public Health and Family Medicine statistician.   
 
Data analysis to show: 
 Total number of lower extremity amputations performed 
 The percentage of lower extremity amputations due to diabetes 
 Distribution of Co-morbid disease 
 Distribution of Risk factors/cause 
 Distribution by age, gender, ethnic breakdown 
 
 
6. ETHICAL CONSIDERATIONS 
 
This proposal will be submitted to the University of Cape Town Human Research Ethics 
Committee. Permission to conduct the study will be obtained from the relevant Medical 













undertaking the study (Part D: Appendix 2). Permission will also be obtained from the 
Research Committee of the Western Cape Department of Health.  
 
Privacy and confidentiality 
Patient confidentiality will be ensured and maintained during the study. Patient names will 
only be used when accessing theatre operation records and to retrieve patient records. These 
names will only be seen by the principal researcher during this period and will be removed 
from the database after the information has been accessed from their records. After this all 
information will be used anonymously. No patient names will be published in the study. 
 
The researcher has no conflict of interest. 
 
 
7. WORK PLAN AND BUDGET 
 
The timeframe for the study involves 5 phases: 
1. Writing and submission of research proposal: January 2011 to June 2011 
2. Collection of data: July 2011 to August 2011 
3. Analysis of data: September 2011 to October 2011 
4. Completion and submission of study: November 2011 to December 2011 
 
The full budget of the study will be the responsibility of the principal researcher. Additional 
funding will be sought from the Department of Family Medicine, Faculty of Health Sciences, 














8. DISSEMINATION OF FINDINGS 
 
The study will be submitted as the thesis portion for the Masters of Medicine degree in 
Family Medicine at the University of Cape Town for 2012. 
 
The results of the study will be made available to the National and Provincial Departments of 
Health, as well as to the Departments of Medicine and Surgery at Groote Schuur, New 
Somerset, Victoria and GF Jooste Hospitals. The findings of the study are expected to 
indicate the level of care that diabetic patients receive. If found to be substandard, this would 
provide evidence that would ultimately improve the services for diabetic patients. 
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Diabetes is a major contributor to morbidity and premature mortality worldwide. The chronic 
complications of diabetes are not only common but also devastating. In the literature, 
diabetes is the most common reported cause of non-trauma related lower extremity 
amputations (LEAs), however there is a lack of such information for South Africa and this 
study attempts to fill in this deficit in data. 
 
Objectives 
The objectives of this study were to examine the proportion of LEAs due to diabetes and to 
describe the demographic characteristics, comorbidities, risk factors, causes, complications, 
number and site of amputation in patients undergoing LEAs.  
 
Methods 
The study consists of three parts and is a retrospective analysis of all LEAs performed in four 
Cape Town public sector hospitals, for 2009 and 2010. The first part of the study identified 
all patients who had a LEA from theatre registers. The second part accessed these patients’ 

















There were 1 280 non-trauma related LEAs in 867 patients, 925 LEAs in 593 diabetic 
patients and 355 LEAs in 274 non-diabetic patients. The main cause for LEAs was ulcer and 
infection in the diabetic and ischaemia in the non-diabetic patients. Smoking was more 
prevalent in the non-diabetic patients. Diabetic patients had more multiple admissions with 
more multiple LEAs than non-diabetic patients. 
 
Conclusions 
The study found the number and percentage (68.4%) of non-trauma related LEAs due to 
diabetes alarmingly high. It is known that the majority of these LEAs are preventable with 
adequate education, screening, treatment and follow up. These findings may be a reflection 
that these patients are receiving suboptimal care and urgent interventions need to be 






















Diabetes is the most common non-communicable disease and a major cause of morbidity and 
mortality globally. Recent estimates are that there were 285 million adults in 2010 and more 
recently 347 million adults with diabetes worldwide.
1,2
 The prevalence of diabetes continues 
to increase, with the largest increase seen in developing countries, including South Africa.
3-5
 
This increase is mainly due to the growth and ageing of the population, as well as increasing 
urbanisation with associated increased levels of obesity, physical inactivity and unhealthy 
diet.
3,5,6
 This increasing number of people with diabetes will impact on health care systems. 
Diabetes accounted for 4.3% of all deaths in South Africa in 2000, placing it as the 7
th
 most 
common cause of death in this country.
3 
 
The complications of diabetes are not only common but devastating and include lower 
extremity amputations (LEAs), blindness and renal failure, with diabetes being the most 
common cause for non-trauma related LEAs.
3
 There is a wide range in the percentage of 
LEAs due to diabetes, with studies showing that up to 90% of LEAs done worldwide are 
associated with diabetes and up to 70% of patients undergoing a lower extremity amputation 
die within five years of the operation.
6 
 
There is a lack of information for diabetic related LEAs in Africa, with no published data 
available for South Africa. This study will attempt to address this deficit in South African 
data, thereby providing a baseline from which further monitoring and planning can occur. 
 
Thus the aim of this study was to examine the contribution of diabetes mellitus to the 













The objectives were to determine the demographic characteristics of patients undergoing 
LEAs, the proportion of these amputations due to diabetes, the co-morbidities, risk factors, 

































The study was a retrospective analysis of all LEAs performed in four Cape Town public 
sector hospitals, Groote Schuur Hospital, a tertiary level hospital, and its associated 
secondary level hospitals, Somerset, Victoria and GF Jooste Hospitals, from 1st January 2009 
to 31st December 2010. These four hospitals are the public sector hospitals performing LEAs 
in the western portion of the Cape Town Metropole. Cape Town is situated in the Western 
Cape province of South Africa and has a heterogeneous population of approximately 3.5 
million people. Like the rest of South Africa, healthcare is split between the public and 





The first part of the study identified cases of LEAs from the theatre registers of these four 
hospitals for 2009 and 2010. The definition of a LEA is the surgical removal of part of the 
lower limb by transection of the leg, foot or digit, and necessarily includes the removal of 
bone.
9
 All cases including the terms above knee amputation (AKA), through knee amputation 
(TKA), below knee amputation (BKA), supra-malleolar amputation (SMA), 
forefoot/transmetatarsal amputation (TMA) and toectomy, were therefore included as a LEA 
in this study. 
 
The second part of the study accessed these patients’ records identified from theatre registers, 
from the corresponding hospitals record departments. Patients whose records were found 















The third part of the study extracted information from the available patients’ records using a 
structured questionnaire (Appendix 1). This information included number and length of 
admissions, demographic details, diabetic status, type and treatment, associated comorbid 
disease, risk factors, cause, amputation details and complications. 
 
Trauma related LEAs were excluded from the study to obtain only information for non-
trauma related LEAs. Of the non-trauma related LEAs, patients whose diabetic status were 
unknown were excluded from the study to only include known diabetic status. 
 
Data was captured in Microsoft Excel 2010. Stata version 11, data analysis and statistical 
software and OpenEpi version 2.3.1, open source epidemiological statistics for public health, 
were used to analyse the data. Descriptive analysis included percentages for categorical data, 
mean, median, standard deviation and range for numerical data. Tests of significance 
included the Chi squared, Fisher exact and the Wilcoxon tests. Statistical significance of 
p<0.05 was used. Assistance with data analysis was sought from the University of Cape 
Town, School of Public Health and Family Medicine statistician. 
 






















Figure 1. Flow diagram for inclusion and exclusion of patients in the study  
     
  
1 517 LEAs in 1 134 patients 
Identified from  

































Diabetic status known 
 







925 LEAs in  
593 Diabetic patients  
355 LEAs in  
274 Non-Diabetic patients  














Figure 1 demonstrates how patients were included and excluded from the study. 
 
Table 1. Comparison of diabetic and non-diabetic patients by gender 
  
      
 
DIABETES YES DIABETES NO 
 
GENDER 








MALE 297 50.1 183 66.8 <0.001 
FEMALE 296 49.9 91 33.2 <0.001 
TOTAL 593 100 274 100   
 
Table 1 compares the demographic characteristics of the patients in the study by gender. This 
demonstrates that the gender distribution was similar in the diabetic group, but in the non-
diabetic group, the percentage of male patients was double that of female patients. There 
were a significantly greater proportion of women with LEAs in the diabetic group than the 
non-diabetic group and the reverse was noted in men. 
 
The mean age of all patients included in the study was 62.2 years, with no significant 
differences between the mean ages of the diabetic and non-diabetic patients. There was no 
significant difference between the mean age of male and female patients in the study. There 
was also no significant difference between the mean age between diabetic and non-diabetic 
patients in the male and female groups of patients.  
 
Unfortunately the ethnic breakdown of the patients in the study was not possible to include in 














The following explains the type of diabetes and the therapy in the diabetic group of patients. 
7 patients (1.2%) had type 1 diabetes, 551 patients (92.9%) had type 2 diabetes and the type 
of diabetes was unknown for 35 of the diabetic patients (5.9%). 3 patients (0.5%) were on no 
therapy, 7 (1.2%) were on diet alone, 299 (50.4%) were on oral therapy alone, 104 (17.5%) 
were on insulin therapy alone, 128 (21.6%) were on a combination of oral and insulin therapy 
and therapy for 52 (8.8%) of the patients was unknown. 
Table 2. Comparison of comorbidities, risk factors, causes and complications between diabetic  
and non-diabetic patients 
      
 











COMORBIDITIES           
HYPERTENSION 493 83.1 148 54.0 <0.001 
CVA/TIA 76 12.8 40 14.6 0.4735 
ISCHAEMIC HEART DISEASE 103 17.4 29 10.6 0.0097 
ALCOHOL 28 4.7 41 15.0 <0.001 
ASTHMA/COPD 24 4.1 27 9.9 <0.001 
CONGESTIVE CARDIAC FAILURE 33 5.6 8 2.9 0.088 
RENAL IMPAIRMENT 28 4.7 3 1.1 0.0074 
HIV 2 0.3 23 8.4 <0.001 
            
RISK FACTORS            
HYPERCHOLESTEROLAEMIA 75 12.7 27 9.9 0.2359 
SMOKING 258 43.5 191 69.7 <0.001 
PERIPHERAL VASCULAR DISEASE 138 23.3 76 27.7 0.1563 
PERIPHERAL NEUROPATHY 13 2.2 3 1.1 0.2653 
            
CAUSES           
ULCER  150 25.3 42 15.3 0.001 
INFECTION 508 85.7 174 63.5 <0.001 
ISCHAEMIA 138 23.3 135 49.3 <0.001 
OTHER CAUSES           
BURNS 7 1.2 0 0.0 0.0346 
MALIGNANCY 2 0.3 12 4.4 <0.001 
DEFORMITY 6 1.0 9 3.3 0.0414 
NEUROLOGICAL DISORDER 1 0.2 7 2.6 0.0034 
HIV VASCULOPATHY 0 0.00 21 7.7 <0.001 













            
COMPLICATIONS           
IN-HOSPITAL DEATH 34 5.7 17 6.2 0.7841 
FURTHER AMPUTATION 250 42.2 63 23.0 <0.001 
BLOOD TRANSFUSION 65 11.0 24 8.8 0.3206 
DIABETIC KETOACIDOSIS 12 2.0 0 0.0 0.0202 
ICU ADMISSION 10 1.7 5 1.8 0.5399 
SEPSIS/DEBRIDEMENT 52 8.8 13 4.7 0.0364 
OTHER COMPLICATIONS           
VASCULAR EVENT 4 0.7 1 0.4 0.9904 
DEEP VEIN THROMBOSIS 0 0.0 1 0.4 0.6321 
UPPER GIT BLEED 3 0.5 2 0.7 0.5048 
PNEUMONIA 2 0.3 0 0.0 0.9351 
OTHER COMPLICATIONS TOTAL  9 1.5 4 1.5 0.9781 
      
CVA=Cerebral Vascular Accident TIA=Transient Ischaemic Attack COPD=Chronic Obstructive Pulmonary  
Disease HIV=Human Immunodeficiency Virus ICU=Intensive Care Unit GIT=Gastrointestinal Tract 
 
Table 2 summarises the comorbidities, risk factors, cause and complications associated with a 
LEA in the diabetic and non-diabetic groups. For associated comorbidities, it can be seen that 
there are significant differences for hypertension, ischaemic heart disease (IHD) and renal 
impairment between the two groups, being more common in the diabetic than the non-
diabetic group. Conversely, there are also significant differences for associated alcohol usage, 
asthma/chronic obstructive pulmonary disease (COPD) and human immunodeficiency virus 
(HIV) infection, which is more common in the non-diabetic than the diabetic group. There 
are no significant differences between associated cerebral vascular accidents 
(CVAs)/transient ischaemic attacks (TIAs) and congestive cardiac failure (CCF) in the 
















For associated risk factors, smoking was significantly different between the two groups, 
being more common in the non-diabetic group compared to the diabetic group. There were no 
significant differences between the two groups for associated hypercholesterolaemia, 
peripheral vascular disease (PVD) and peripheral neuropathy. 
 
For causes of the LEAs, there were significant differences for the main causes between the 
two groups, with ulcer and infection being more common in the diabetic group and ischaemia 
being more common in the non-diabetic group. There were also significant differences for the 
other causes between the two groups, with burns being more common in the diabetic group 
and malignancy, limb deformity, neurological disorder and HIV vasculopathy being more 
common in the non-diabetic group. 
 
For complications associated with the LEA, there were significant differences for the main 
complications between the two groups, with a further LEA, diabetic ketoacidosis (DKA) and 
sepsis and debridement being more common in the diabetic group than the non-diabetic 
group. There were no significant differences for the other main complications of in-hospital 
death, blood transfusion, and intensive care unit (ICU) admission, as well as the other 
complications of deep vein thrombosis (DVT), upper gastrointestinal tract (GIT) bleed and 

















Table 3. Comparison of length of admissions in days between diabetic and non-diabetic patients 
 
      DIABETES NUMBER MEAN MEDIAN STD DEV MIN MAX 
YES 688 10.6 9 6.4 1 45 
NO 300 10.7 9 8.3 1 79 
TOTAL 988 10.6 9 7.0 1 79 
 
      Two-sample Wilcoxon rank-sum test: p=0.7995 
    
      STD DEV = Standard deviation MIN = Minimum in range MAX = Maximum in range 
  
Table 3 shows that the mean length of admission for all patients was 10.6 days and there was 
no significant difference between the mean length of admission for the diabetic and non-
diabetic patients.  
 
When analysing admissions, 867 patients in the study were admitted a total of 988 times, 
with the 593 diabetic patients being admitted 688 times and the 274 non-diabetic patients 
being admitted 300 times. A significantly greater proportion of the diabetic patients (14.3%) 
had multiple admissions compared to the non-diabetic patients (7.7%) and conversely a 
greater proportion of non-diabetic patients (92.3%) had a single admission compared to the 


















Table 4. Comparison of previous and current Lower Extremity Amputations between diabetic and 
non-diabetic patients 
      
 










PATIENTS p value 
PREVIOUS LEA           
SINGLE 97 16.4 41 15.0 0.6019 
MULTIPLE 24 4.1 6 2.2 0.1643 
TOTAL 121 20.4 47 17.2 0.261 
            
CURRENT LEA           
SINGLE 344 58.0 211 77.0 <0.001 
MULTIPLE 249 42.0 63 23.0 <0.001 
TOTAL 593 100 274 100   
 
 
Table 4 shows that 168 of the total 867 patients (19.4%) in the study had a previous LEA 
before the study period of 2009. There was no significant difference in having a previous 
LEA or having single or multiple LEAs between the two groups. It can be seen that for the 
current LEAs, there was a significant difference in LEAs with the diabetic group having a 

























TMA=Transmetatarsal Amputation SMA=Supra-malleolar Amputation BKA=Below Knee Amputation 






























































Site of LEA 





























































Site of LEA 













Figure 2 shows the breakdown in number and percentage for the sites of the current LEAs in 
the diabetic and non-diabetic groups. There were a total of 1 280 LEAs in all patients over the 
study period, 925 LEAs in 593 diabetic patients and 355 LEAs in 274 non-diabetic patients. 
It can be seen that the number of LEAs at all sites except TKAs were higher in the diabetic 
group than the non-diabetic group. It can also be seen that the percentages of LEAs at all the 

























This study showed that 1 517 LEAs were identified over the two year study period. A
previous unpublished study found that 1 483 LEAs were identified over a three year study
period, from 1997 to 1999, for the same patient population attending public sector hospitals
in the Cape Town Metropole. That study found that 60.2%, where this study found that 
68.4% of the non-trauma related LEAs were related to diabetes.
10
This increase in number of 
LEAs and percentage due to diabetes over this time period is probably a reflection of not only
the increasing size of the population, but also due to the increase in the incidence of diabetes
and its complications, including LEAs.
A previous study has shown that the proportion of males to females in both diabetic and non-
diabetic related LEA patients were equal.
11
This study has shown that this was true for the
diabetic patients, but more males had LEAs in the non-diabetic group compared to females. 
This may be due to the higher prevalence of smoking in males in the non-diabetic group, with 
smoking being a major risk factor for a LEA.
12
There was no difference found in the mean ages of all patients in this study, male and female, 
diabetic and non-diabetic. A previous study has shown similar findings but with higher 
ages.
11
 These lower ages in this study may be a reflection of more advanced disease in our
patients due to suboptimal care.  
92.9% of the diabetic patients requiring a LEA had type 2 diabetes, which is in keeping with 
other data worldwide including Africa.
13,14













until the presentation of a complication (retinopathy, nephropathy and neuropathy).
15
 Where 
50% of the diabetic patients were on oral therapy alone, nearly 40% were either on a 
combination of oral and insulin or insulin therapy alone. This high percentage of insulin 
usage may be a reflection that a large proportion of the patients’ diabetes was not adequately 
controlled, requiring additional therapy.  
 
This study found that the associated comorbidities of hypertension, IHD and renal 
impairment were more common in the diabetic group of patients. This is in keeping with 
what previous studies have shown and is thought to be partly due to the increasing 
westernisation of lifestyles.
3,12,13
 The associated renal impairment is probably a reflection of 
the other associated complications of diabetes.  
 
Smoking was the only associated risk factor found to be different between the diabetic and 
non-diabetic groups in this study. It was more prevalent in the non-diabetic patients and this 
was also reflected in the fact that associated asthma/COPD was also more prevalent in the 
non-diabetic group. There were still a large proportion of diabetic patients who smoked, 
which has been shown to increase the risk of LEAs.
12
 Associated PVD was similar between 
the diabetic and non-diabetic groups with about 25% of patients noted to have PVD as a risk 
factor, which is a similar finding to a previous study.
11
 This study only found a small number 
of patients with associated peripheral neuropathy in both groups, especially in the diabetic 
group, where peripheral neuropathy is known to be a substantial cause of foot complications 
including LEAs.
14,16
 The number of patients with associated peripheral neuropathy is thought 












A preceding ulcer and infection were the more common causes for LEAs in the diabetic 
patients, which is in keeping with what previous studies have shown.
6,12,17
 Ischaemia was the 
more common cause for LEAs in the non-diabetic patients and is probably due to the higher 
rate of smoking in this group. Burns causing LEAs was more common in the diabetic group 
and can probably be attributed to associated peripheral neuropathy, although the number of 
these patients was low as described above. 
 
This study was unable to assess the proportion of patients who died after they had a LEA and 
discharged from hospital. The study did however assess the proportion of patients who died 
in hospital after having a LEA and no difference was found between the diabetic and non-
diabetic groups. A portion of folders of deceased patients at one of the hospitals in the study 
was inaccessible. Due to the high percentage of diabetes found in this study, it is felt that the 
rate of in-hospital deaths in diabetic patients could be higher than reported.  
 
Post LEA sepsis and debridements were found to be more common in the diabetic group of 
patients. This is expected as sepsis was often the cause for the LEA in this group. This is 
suspected to be an underestimate of the true rate because only admissions where a LEA took 
place were included in this study. It was noticed that there were many more admissions for 
these patients for sepsis and/or debridement before or after an admission for a LEA. 
 
This study found that there was no difference in the mean length of admissions for all 
patients. It was also found that the diabetic patients had more multiple admissions and 












during the same or on subsequent admissions and were generally due to on-going sepsis 
and/or ulcer. 
 
The percentages for the site of the current LEAs shows that nearly 20% were SMAs. This is 
an indication that sepsis was a major cause as this operation is usually a sepsis control 
procedure, the definitive procedure being a BKA or AKA, depending on the status of the 
remaining limb. It is also notable that the percentage of AKAs in the non-diabetic group is 
double that of the diabetic group. This may be a reflection that diabetic patients have more 
LEAs due to an ulcer or infection requiring a more distal amputation whereas the non-
diabetic patients have more LEAs due to ischaemia, requiring a more proximal amputation.  
 
It is well known that the majority of foot complications, including, LEAs are preventable 
with adequate patient education, screening, treatment and follow up.
17-20
 Unfortunately, the 
high numbers of LEAs that are occurring may be a reflection that this care is suboptimal. 
This may be due to high patient numbers and decreased consultation times leading to 
infrequent foot examinations, decreased patient education and therefore non-compliance, as 
well as inadequate treatment at a primary healthcare level. There is also a lack of resources 
like podiatrists needed to adequately treat these complications.
3,18 
 
Numerous studies have stated that LEAs are a considerable cost for healthcare services, not 
only for the admission and amputation, but also for the additional costs of rehabilitation, 
home care and social services.
21-23
 The human cost is also considerable, for the patient, their 












complications including LEAs. Detailed costing for the number of LEAs that have taken 
place needs to be undertaken.  
 
Due to the lack of accurate data on diabetic incidence and population size in the study area, it 
is difficult to extrapolate the number of LEAs that have been identified in this study to the 
























LIMITATIONS OF THE STUDY 
Where there were strengths in this study due to the large number of patients identified and 
evaluated due to a good recovery rate, there were also weaknesses. Numbers for certain 
associated factors in these patients were low and meaningful analysis was not always 
possible. The retrospective nature of this study only allowed for information that was 
recorded in the patient records to be evaluated. Record taking was often poor with very 
limited information in the records. Associated information like the level of glycaemic control, 
length of diabetes and obesity that could have been useful was not available. Also, this study 
only evaluated patients accessing the public sector, thereby underestimating the true 






















CONCLUSIONS AND RECOMMENDATIONS 
This study set out to describe the contribution of diabetes to the performance of LEAs in the 
public healthcare sector in Cape Town and found this number to be alarmingly high. The 
associated factors in these patients, age, gender, comorbid disease, risk factors, cause, 
complications and amputations were all generally similar to what previous studies, all outside 
South Africa, had shown. This study therefore sets a baseline for South African information, 
from which further assessment and planning can occur. 
 
It has been mentioned that the majority of complications including LEAs are preventable 
with adequate education, screening, treatment and follow up. This has however been shown 
to be suboptimal. It is recommended that these basic services need to be improved at a 
primary care level in order to begin to decrease the number of LEAs that are being 
performed, as well as the other devastating complications of blindness and renal failure. 
Healthcare workers need to be educated on how to use well described treatment guidelines 
including foot screening tools, enough time during a consultation needs to take place with a 
patient to allow education, screening and active participation in their treatment. It simply 
comes down to the old adage of “prevention is better than cure”, unfortunately not so simple 
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Case number:     Date:  
 
Hospital: Groote Schuur       New Somerset       Victoria       GF Jooste 
 
Date of admission: 
 
Date of operation/s: 
 
Date of discharge: 
 










Date of birth/age: 
 
Gender: Male  Female 
 
Ethnicity: Black 
  Coloured 
  Indian 






Patient diabetic? Yes  No 
 
Type of diabetes: Type 1  Type 2 
 
Diabetic treatment: Diet only 
   Oral therapy 
   Insulin therapy 
















Hypertension:   Yes   No  Unknown 
CVA/TIA:   Yes  No  Unknown 
Dyslipidaemia:  Yes  No  Unknown 
IHD    Yes  No  Unknown 
Smoking:   Yes  No  Unknown 
Alcohol:   Yes  No  Unknown 
PVD:    Yes  No  Unknown 




Ulcer:    Yes  No  Unknown 
Infection:   Yes  No  Unknown 
Arterial embolism:  Yes  No  Unknown 
Trauma:   Yes  No  Unknown 
Burns:    Yes  No  Unknown 
Malignancy:   Yes  No  Unknown 




Previous amputation/s:  Yes  No 
 
If yes:   Side  Level 
One:   …….  ……. 
Two:   …….  ……. 
Three:   …….  ……. 





Number of amputations during current hospital admission: 
 
   Side  Level 
First:   …….  ……. 
Second:  …….  ……. 



















         01 June 2011 
 
The Medical Superintendent 
 
Re: Permission to undertake study. 
As part of the MMed in Family Medicine at the University of Cape Town, I am planning to 
undertake the following study. The contribution of diabetes mellitus to lower extremity 
amputations in four public sector hospitals in Cape Town, for 2009 and 2010. 
 
I will require permission to firstly access theatre operating records of all lower extremity 
amputations done in the hospital from 2009 to 2010; and secondly access patient records for 
those identified having these amputations. 
 
Patient confidentiality will be maintained throughout the study and patient information will 
be used anonymously.  
 




Dr Graeme Dunbar 
 
 
Registrar in Family Medicine 
School of Public Health & Family Medicine 
Faculty of Health Sciences 
University of Cape Town 
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Instructions to authors for Publication-ready format, taken from: 
1. South African Medical Journal, Submissions, Author Guidelines. 
Available from: http://www.samj.org.za/index.php/samj/about/submissions 
(Accessed 01 July 2012) 
2. International Committee of Medical Journal Editors. Uniform Requirements for 
Manuscripts Submitted to Biomedical Journals: Manuscript Preparation and 
Submission: Preparing a Manuscript for Submission to a Biomedical Journal. 
Available from: http://www.icmje.org/manuscript_1prepare.html 
(Accessed 01 July 2012) 
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were removed from the database after the information was accessed from their records. No 
patient names were published in the study. 
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 TECHNICAL APPENDICES 
Additional Tables 5 to 7 
Additional Figure 3 
Table 5. Comparing ages of patients in years according to diabetic status and gender 
DIABETES NUMBER MEAN MEDIAN STD DEV MIN MAX 
YES 593 62.6 63 10.9 29 93 
NO 274 61.5 63 16.1 14 91 
TOTAL 867 62.2 63 12.8 14 93 
Two-sample Wilcoxon rank-sum test: p = 0.9204 
GENDER NUMBER MEAN MEDIAN STD DEV MIN MAX 
MALE 480 60.9 63 12.4 14 93 
FEMALE 387 63.8 65 13.1 14 91 
TOTAL 867 62.2 63 12.8 14 93 
Two-sample Wilcoxon rank-sum test: p = 0.9204
FEMALE PATIENTS 
DIABETES NUMBER MEAN MEDIAN STD DEV MIN MAX 
YES 296 63.6 64 11.0 29 87 
NO 91 64.8 70 18.3 14 91 
TOTAL 387 63.8 65 13.1 14 91 
Two-sample Wilcoxon rank-sum test: p = 0.3140 
MALE PATIENTS 
DIABETES NUMBER MEAN MEDIAN STD DEV MIN MAX 
YES 297 61.6 63 10.7 31 93 
NO 183 59.8 61 14.7 14 90 
TOTAL 480 60.9 63 12.4 14 93 
Two-sample Wilcoxon rank-sum test: p = 0.3321 











The demographic characteristics of all the patients by age and gender are shown in Table 5. 
The mean age of all patients included in the study was 62.2 years, with no significant 
difference between the mean ages of the diabetic and non-diabetic patients. Where the 
maximum age for patients in both groups were similar, it was clear that the minimum age was 
higher in the diabetic group (29 years) compared to the non-diabetic group (14 years). There 
was no significant difference between the mean age of male and female patients in the study. 
There was also no significant difference between the mean age between diabetic and non-
diabetic patients in the male and female groups of patients.  
Table 6. Number and percentage of diabetic patients according to type and therapy
DIABETES TYPE NUMBER OF PATIENTS PERCENTAGE OF PATIENTS 
TYPE 1 7 1.2 
TYPE 2 551 92.9 
TYPE UNKNOWN 35 5.9 
TOTAL 593 100.00 
THERAPY NUMBER OF PATIENTS PERCENTAGE OF PATIENTS 
RX NONE 3 0.5 
RX DIET 7 1.2 
RX ORAL 299 50.4 
RX INSULIN 104 17.5 
RX ORAL AND INSULIN 128 21.6 
RX UNKNOWN 52 8.8 
TOTAL 593 100.00 
The first part of Table 6 shows the number and percentage of diabetic patients according to 
their type of diabetes. It can clearly be seen that the vast majority of the patients (92.9%) 
were type 2 diabetics. The second part of Table 6 shows the number and percentage of 











were on oral therapy alone and 17.5% of the patients were on insulin therapy alone. Nearly a 
quarter (21.6%) of the patients were on a combination of oral and insulin therapy. 
Table 7. Comparison of single and multiple admissions by diabetic status 










SINGLE 508 85.7 253 92.3 0.0053 
MULTIPLE 85 14.3 21 7.7 0.0053 
TOTAL 593 100 274 100 
When comparing single and multiple admissions, it was found that 85.7% of the diabetic
patients had a single admission and the remaining 14.3% multiple admissions. 92.3% of the
non-diabetic patients had a single admission and the remaining 7.7% non-diabetic patients 
had multiple admissions. There was a significant difference between the percentage of single
and multiple admissions between the diabetic and non-diabetic patients, with the diabetic












Figure 3. Number and percentage for site of previous Lower Extremity Amputations 
TMA=Transmetatarsal Amputation SMA=Supra-malleolar Amputation BKA=Below Knee Amputation 



























































Site of LEA 































































Site of LEA 











The first part of Figure 3 shows that for previous LEAs, the number of LEAs at all sites were 
higher for the diabetic group than the non-diabetic group. The second part of Figure 3 shows 
that by percentage, there were more LEAs for the diabetic group for single toectomies, supra-
malleolar amputations, below knee amputations and through knee amputations. The non-
diabetic group had a higher percentage of multiple toectomies, transmetatarsal amputations 
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School of Public Health & Family Medicine 
Falmouth Building 
Faculty: Health Sciences 
E-mail : graeme .michelle@iburst.co.zo 
Dear Dr Dunbar 
. , 
DIRECTORATE: HEAL T'1 
Groote Schwr Hospita 
Enquiries: Dr Bhavna Pate-
E·mall: Bhavna.Pate1@pgwc.qav.2a 
RESEARCH: The contribution of Diabetes Mellitus to lower Extremity Amputations 
in Four Public Sector Hospitals in Cape Town for 2009/2010. (Access to GSH 
Theatre Records and Patient Folders) 
Your request dated 23 January 2012 has reference. 
Permission is granted for you and your research assistant to access the GSH 
Theatre registers and patient folders. 
Please note the following: 
a) Your research may not interfere with normal patient care 
b) Hospital staff may not be asked to assist with the research. 
c) No hospital consumables and stationary may be used. 
d) Please arrange access to patient folders with Mr Noel Weeder: Medical 
Records on 021-404-4058 or 4060. 
e) No patient folders may be removed from the premises or be inaccessible. 
f) Please introduce yourself to the Theatre Manager of the area before 
commencing. 
g) Confidentiality must be maintained at all times. 
G46 Management Suite, Old Main Buiding, 
Observatory 7925 












I would like to wish you every success with the project. 
Yours sincerely 
DR BHAVNA PATEL 
SENIOR MANAGER: MEDICAL SERVICES 
Date: 241h January 2012 
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